{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T09:02:15Z","timestamp":1768640535445,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Chinese National Natural Science Foundation","doi-asserted-by":"crossref","award":["81960023"],"award-info":[{"award-number":["81960023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11800-x","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T06:04:25Z","timestamp":1765087465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HMGB1 and metabolic pathways in Acinetobacter baumannii pneumonia: an associative study"],"prefix":"10.1186","volume":"26","author":[{"given":"Mingshan","family":"Xue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianyue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangkai Jason","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaohui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baojun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runpei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youli","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongman","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"key":"11800_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.mib.2018.04.004","volume":"45","author":"KL Wyres","year":"2018","unstructured":"Wyres KL, Holt KE. Klebsiella pneumoniae as a key trafficker of drug resistance genes from environmental to clinically important bacteria. Curr Opin Microbiol. 2018;45:131\u20139.","journal-title":"Curr Opin Microbiol"},{"key":"11800_CR2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01083-19","author":"V Trebosc","year":"2019","unstructured":"Trebosc V, et al. Dissecting colistin resistance mechanisms in extensively drug-resistant Acinetobacter baumannii clinical isolates. mBio. 2019. https:\/\/doi.org\/10.1128\/mBio.01083-19.","journal-title":"mBio"},{"issue":"1","key":"11800_CR3","first-page":"35","volume":"24","author":"T Bein","year":"2018","unstructured":"Bein T, Weber-Carstens S, Apfelbacher C. Long-term outcome after the acute respiratory distress syndrome: different from general critical illness? Curr Opin Crit Care. 2018;24(1):35\u201340.","journal-title":"Curr Opin Crit Care"},{"issue":"6","key":"11800_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jinf.2019.09.012","volume":"79","author":"MS Lim","year":"2019","unstructured":"Lim MS. The global prevalence of multidrug-resistance among acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: A systematic review and meta-analysis. J Infect. 2019;79(6):593\u2013600.","journal-title":"J Infect"},{"issue":"1","key":"11800_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1189\/jlb.0306200","volume":"81","author":"A Rouhiainen","year":"2007","unstructured":"Rouhiainen A, et al. Pivotal advance: analysis of Proinflammatory activity of highly purified eukaryotic Recombinant HMGB1 (amphoterin). J Leukoc Biol. 2007;81(1):49\u201358.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"11800_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/cc6935","volume":"12","author":"B Kornblit","year":"2008","unstructured":"Kornblit B, et al. Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome. Crit Care. 2008;12(3):R83.","journal-title":"Crit Care"},{"issue":"1","key":"11800_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-020-00172-4","volume":"26","author":"U Andersson","year":"2020","unstructured":"Andersson U, Ottestad W, Tracey KJ. Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19? Mol Med. 2020;26(1):42.","journal-title":"Mol Med"},{"key":"11800_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.imlet.2021.10.005","volume":"240","author":"Y Li","year":"2021","unstructured":"Li Y, et al. Neonatal Streptococcus pneumoniae pneumonia induces airway SMMHC expression through HMGB1\/TLR4\/ERK. Immunol Lett. 2021;240:149\u201358.","journal-title":"Immunol Lett"},{"issue":"1","key":"11800_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-022-00535-z","volume":"28","author":"F De Leo","year":"2022","unstructured":"De Leo F, et al. Pamoic acid is an inhibitor of HMGB1.CXCL12 elicited chemotaxis and reduces inflammation in murine models of Pseudomonas aeruginosa pneumonia. Mol Med. 2022;28(1):108.","journal-title":"Mol Med"},{"issue":"1","key":"11800_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2119\/molmed.2012.00024","volume":"18","author":"M Entezari","year":"2012","unstructured":"Entezari M, et al. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas aeruginosa pneumonia in cystic fibrosis. Mol Med. 2012;18(1):477\u201385.","journal-title":"Mol Med"},{"issue":"1","key":"11800_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-022-01254-1","volume":"48","author":"Y Fan","year":"2022","unstructured":"Fan Y, et al. Investigation of the relationship between community-acquired respiratory distress syndrome toxin and the high-mobility group box protein 1-toll-like receptors-myeloid differentiation factor 88 signaling pathway in Mycoplasma pneumoniae pneumonia. Ital J Pediatr. 2022;48(1):64.","journal-title":"Ital J Pediatr"},{"issue":"21","key":"11800_CR12","doi-asserted-by":"publisher","first-page":"9618","DOI":"10.1128\/JVI.01279-16","volume":"90","author":"YM Hosakote","year":"2016","unstructured":"Hosakote YM, et al. Respiratory syncytial virus infection triggers epithelial HMGB1 release as a damage-associated molecular pattern promoting a monocytic inflammatory response. J Virol. 2016;90(21):9618\u201331.","journal-title":"J Virol"},{"issue":"4","key":"11800_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1084\/jem.192.4.565","volume":"192","author":"U Andersson","year":"2000","unstructured":"Andersson U, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 2000;192(4):565\u201370.","journal-title":"J Exp Med"},{"issue":"1","key":"11800_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1073\/pnas.2434651100","volume":"101","author":"H Yang","year":"2004","unstructured":"Yang H, et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A. 2004;101(1):296\u2013301.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4\u20136","key":"11800_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2119\/2006-00010.Yang","volume":"12","author":"R Yang","year":"2006","unstructured":"Yang R, et al. Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol Med. 2006;12(4\u20136):105\u201314.","journal-title":"Mol Med"},{"issue":"6","key":"11800_CR16","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.4049\/jimmunol.165.6.2950","volume":"165","author":"E Abraham","year":"2000","unstructured":"Abraham E, et al. HMG-1 as a mediator of acute lung inflammation. J Immunol. 2000;165(6):2950\u20134.","journal-title":"J Immunol"},{"key":"11800_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.738074","volume":"11","author":"C Huang","year":"2021","unstructured":"Huang C, et al. A microbial world: could metagenomic next-generation sequencing be involved in acute respiratory failure? Front Cell Infect Microbiol. 2021;11:738074.","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"11800_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016;17(7):451\u20139.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"11800_CR19","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1164\/rccm.201103-0474CI","volume":"184","author":"NJ Serkova","year":"2011","unstructured":"Serkova NJ, Standiford TJ, Stringer KA. The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am J Respir Crit Care Med. 2011;184(6):647\u201355.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"11800_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11684-014-0318-2","volume":"8","author":"X Liu","year":"2014","unstructured":"Liu X, Ren H, Peng D. Sepsis biomarkers: an omics perspective. Front Med. 2014;8(1):58\u201367.","journal-title":"Front Med"},{"issue":"6","key":"11800_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41580-019-0108-4","volume":"20","author":"MM Rinschen","year":"2019","unstructured":"Rinschen MM, et al. Identification of bioactive metabolites using activity metabolomics. Nat Rev Mol Cell Biol. 2019;20(6):353\u201367.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"11800_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-065871","volume":"375","author":"C Cilloniz","year":"2021","unstructured":"Cilloniz C, Torres A, Niederman MS. Management of pneumonia in critically ill patients. BMJ. 2021;375:e065871.","journal-title":"BMJ"},{"issue":"3","key":"11800_CR23","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1183\/09031936.00100812","volume":"42","author":"S Aliberti","year":"2013","unstructured":"Aliberti S, et al. Criteria for clinical stability in hospitalised patients with community-acquired pneumonia. Eur Respir J. 2013;42(3):742\u20139.","journal-title":"Eur Respir J"},{"issue":"9474","key":"11800_CR24","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/S0140-6736(05)66621-4","volume":"365","author":"JJ McMurray","year":"2005","unstructured":"McMurray JJ, Pfeffer MA. Heart failure. Lancet. 2005;365(9474):1877\u201389.","journal-title":"Lancet"},{"issue":"9818","key":"11800_CR25","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815\u201322.","journal-title":"Lancet"},{"issue":"2","key":"11800_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nrneph.2016.163","volume":"13","author":"RJ Glassock","year":"2017","unstructured":"Glassock RJ, Warnock DG, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13(2):104\u201314.","journal-title":"Nat Rev Nephrol"},{"issue":"Suppl1","key":"11800_CR27","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1016\/j.jhep.2004.11.015","volume":"42","author":"F Durand","year":"2005","unstructured":"Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005;42(Suppl1):S100\u20137.","journal-title":"J Hepatol"},{"issue":"1","key":"11800_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jhep.2019.08.032","volume":"72","author":"G Berardi","year":"2020","unstructured":"Berardi G, et al. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis. J Hepatol. 2020;72(1):75\u201384.","journal-title":"J Hepatol"},{"issue":"7","key":"11800_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102482","volume":"9","author":"Y Sadamura-Takenaka","year":"2014","unstructured":"Sadamura-Takenaka Y, et al. Hmgb1 promotes the development of pulmonary arterial hypertension in rats. PLoS ONE. 2014;9(7):e102482.","journal-title":"PLoS ONE"},{"issue":"3","key":"11800_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089450","volume":"9","author":"G Gong","year":"2014","unstructured":"Gong G, et al. Protective effect of glycyrrhizin, a direct HMGB1 inhibitor, on focal cerebral ischemia\/reperfusion-induced inflammation, oxidative stress, and apoptosis in rats. PLoS ONE. 2014;9(3):e89450.","journal-title":"PLoS ONE"},{"key":"11800_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104911","volume":"138","author":"M Shahjaman","year":"2021","unstructured":"Shahjaman M, et al. rMisbeta: a robust missing value imputation approach in transcriptomics and metabolomics data. Comput Biol Med. 2021;138:104911.","journal-title":"Comput Biol Med"},{"issue":"3","key":"11800_CR32","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41401-021-00676-7","volume":"43","author":"C Deng","year":"2022","unstructured":"Deng C, et al. Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury. Acta Pharmacol Sin. 2022;43(3):520\u20138.","journal-title":"Acta Pharmacol Sin"},{"key":"11800_CR33","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00234-20","author":"CL Holmes","year":"2021","unstructured":"Holmes CL, et al. Pathogenesis of gram-negative bacteremia. Clin Microbiol Rev. 2021. https:\/\/doi.org\/10.1128\/CMR.00234-20.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"11800_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/01.shk.0000225404.51320.82","volume":"26","author":"M Yu","year":"2006","unstructured":"Yu M, et al. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock. 2006;26(2):174\u20139.","journal-title":"Shock"},{"issue":"4","key":"11800_CR35","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.bbalip.2014.10.008","volume":"1851","author":"WS Powell","year":"2015","unstructured":"Powell WS, Rokach J. Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid. Biochim Biophys Acta. 2015;1851(4):340\u201355.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"11800_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0952-3278(97)90518-4","volume":"56","author":"D Reynaud","year":"1997","unstructured":"Reynaud D, Pace-Asciak CR. 12-HETE and 12-HPETE potently stimulate intracellular release of calcium in intact human neutrophils. Prostaglandins Leukot Essent Fatty Acids. 1997;56(1):9\u201312.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"14","key":"11800_CR37","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1016\/j.cub.2020.05.030","volume":"30","author":"H Poplimont","year":"2020","unstructured":"Poplimont H, et al. Neutrophil swarming in damaged tissue is orchestrated by connexins and cooperative calcium alarm signals. Curr Biol. 2020;30(14):2761\u2013e27767.","journal-title":"Curr Biol"},{"issue":"1","key":"11800_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/cc12493","volume":"17","author":"S Matsuo","year":"2013","unstructured":"Matsuo S, et al. Cyclic arginine-glycine-aspartate attenuates acute lung injury in mice after intestinal ischemia\/reperfusion. Crit Care. 2013;17(1):R19.","journal-title":"Crit Care"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11800-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11800-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11800-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:04:10Z","timestamp":1768557850000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-11800-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["11800"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11800-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"19 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted with informed consent from all subjects and was approved by the Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University, with Ethics No. 2022\u2009\u2212\u2009121. This experiment complies with ARRIVE guidelines and has been approved by the Experimental Animal Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University, Ethics No. 20230329.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}